Read news as it happens
Create a Rediffmail account
Subscribe via RSS
Why Sun Pharma stock will remain under pressure
The weakness in the stock was because of inspections by the American drug regulator at its Halol plant in Gujarat which resulted in eight observations, as well as a downward revision of speciality......
Markets end in green amid volatile trade
The S&P BSE Sensex ended up 45 points at 25330 and the Nifty50 closed 11 points higher at 7,715. In the broader markets, the BSE Midcap and Smallcap indices ended up 0.3%-0.5% each. “Recently......
Pharma in 2014: Deals worth billions and fines worth millions
Even as private firms were busy stitching merger and partnership deals, the government also remained active during the year working on a separate policy to promote and strengthen domestic......
Sensex logs biggest single-day drop this year; sheds 538 points
The 30-share Sensex ended down 538 points at 26,781 and 50-share Nifty ended down 152 points at 8,067. BBenchmark share indices ended at seven-week lows after sharp decline in the rupee,......
Ranbaxy brand may fade away as Sun takes charge
The Ranbaxy brand might be gradually phased out in the near future in the wake of this year’s largest merger in the Asian pharma sector. After Monday’s conditional nod from the......
bharatiya janata party
united progressive alliance
national democratic alliance
rashtriya swayamsevak sangh
central bureau of investigation
Top Coverage News
US Presidential Elections 2016
Coming to India and making
Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
India, through the eye of a camera
Commonwealth Games - 2014
The defence coverage of Rediff.com
Office email App
© 2020 Rediff.com